Analysts expect Vivos Therapeutics, Inc. to report revenue of 6.55 M for Q3 26, against a range of 6.03 M to 7.06 M. The most recent reported quarter, Q2 26, came in at 5.15 M, a 13.9% miss against the 5.98 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 3.90 M | 3.70 M | 3.02 M | 3.82 M | 6.78 M | 3.82 M | 5.14 M | 5.15 M | - | - | - | - | - | - | - | - | ||
| High Estimate | 4.22 M | 3.87 M | 3.79 M | 3.66 M | 4.86 M | 8.23 M | 4.53 M | 6.27 M | 7.06 M | 7.69 M | 5.56 M | 6.59 M | 10.00 M | 11.08 M | 8.87 M | 8.91 M | ||
| Low Estimate | 3.65 M | 3.41 M | 3.14 M | 3.40 M | 4.05 M | 6.82 M | 3.86 M | 5.69 M | 6.03 M | 6.78 M | 4.79 M | 5.92 M | 9.08 M | 9.64 M | 7.26 M | 8.04 M | ||
| Consensus Estimate | 3.94 M | 3.64 M | 3.46 M | 3.53 M | 4.45 M | 7.53 M | 4.19 M | 5.98 M | 6.55 M | 7.24 M | 5.18 M | 6.25 M | 9.54 M | 10.36 M | 8.07 M | 8.47 M |
Analysts expect Vivos Therapeutics, Inc. to report earnings per share of -0.20 for Q3 26, against a range of -0.21 to -0.19. The most recent reported quarter, Q2 26, came in at -0.31, a 22.5% beat against the -0.40 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.40 | 0.41 | -0.45 | -0.55 | -0.49 | -0.58 | -0.52 | -0.31 | - | - | - | - | - | - | - | - | ||
| High Estimate | -0.59 | -0.36 | -0.37 | -0.35 | -0.45 | -0.43 | -0.43 | -0.37 | -0.19 | -0.13 | -0.54 | -0.55 | -0.18 | -0.04 | -0.53 | -0.47 | ||
| Low Estimate | -0.69 | -0.40 | -0.39 | -0.39 | -0.55 | -0.53 | -0.49 | -0.43 | -0.21 | -0.13 | -0.64 | -0.59 | -0.22 | -0.04 | -0.57 | -0.57 | ||
| Consensus Estimate | -0.64 | -0.38 | -0.38 | -0.37 | -0.50 | -0.48 | -0.46 | -0.40 | -0.20 | -0.13 | -0.59 | -0.57 | -0.20 | -0.04 | -0.55 | -0.52 |
Pull Wall Street consensus for Vivos Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=VVOS&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "VVOS", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=VVOS&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();